Patient: Page 7


  • Murray Aitken IQVIA Institute
    Image attribution tooltip
    Permission granted by Murray Aitken/IQVIA Institute
    Image attribution tooltip
    Q&A

    IQVIA’s OG of data analytics on the latest clinical trial trends

    IQVIA Institute’s Murray Aitken is the man behind the numbers, and here, shares the newest findings on clinical trial burnout, diversity and more.

    By March 10, 2023
  • Senior older women
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Targeting the new ‘Golden Girls’

    With unprecedented buying power, women over 50 wield a lot of influence — but are still underserved by pharma. Urovant hopes to change that with its potential blockbuster drug.

    By March 8, 2023
  • clinical trial diversity Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • storytelling marketing
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    3 keys to good storytelling in pharma

    The CEO of Complement Therapeutics shares simple storytelling tactics lead to maximum impact.

    By Alexandra Pecci • March 7, 2023
  • silhouette people
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    PharmaVoice 100 honorees: Where are they now?

    How some of our past PharmaVoice 100 honorees are transforming the life sciences industry in new roles. 

    By , Karissa Waddick • March 3, 2023
  • drug injection cost
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Multimillion-dollar therapies are changing how payers foot the bill

    With more gene therapies headed to market, novel payment methods are emerging from regulators and academia. 

    By Feb. 28, 2023
  • A sign for the Food and Drug Administration is seen on July 20, 2020 in Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Reata’s stock plummets amid sudden FDA neuro office shakeup

    The FDA’s longtime neuroscience head Billy Dunn stepped down, leaving industry reeling over how the agency’s new acting director could handle upcoming approval decisions.

    By Karissa Waddick • Feb. 28, 2023
  • patient care
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A

    Why patient care is a public affair

    The VP of public affairs at Kyowa Kirin discusses her role in advocating for advocacy.

    By Feb. 23, 2023
  • Will Chou headshot
    Image attribution tooltip
    Permission granted by Dr. William Chou, Passage Bio
    Image attribution tooltip
    Q&A

    Managing for resilience: Passage’s ups and downs in gene therapy

    After a rocky year, Passage Bio’s CEO is focused on helping the rare disease specialist bounce back.

    By Feb. 15, 2023
  • Ester Banque Bristol Myers Squibb
    Image attribution tooltip
    Permission granted by Ester Banque Bristol Myers Squibb
    Image attribution tooltip
    Podcast

    Woman of the Week: Bristol Myers Squibb’s Ester Banque

    The 30-year veteran is heading up the “transformation” of one of the pharma giant’s most important therapeutic portfolios: hematology.

    By Feb. 15, 2023
  • Multicolored wave lines in the shape of an eye
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Profile

    For Complement’s CEO, storytelling could be just as critical as data

    Dr. Rafiq Hasan has his sights on bringing lessons learned at Bayer to ophthalmology-focused Complement Therapeutics.

    By Alexandra Pecci • Feb. 14, 2023
  • mental health concept
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Why are there gaps in mental healthcare? Often it’s flawed trial methodology

    Sunovion Pharmaceuticals has developed a more precise way to track symptoms that could be broadly adopted across the industry.

    By Kelly Bilodeau • Feb. 10, 2023
  • Professional headshot of Tamar Thompson
    Image attribution tooltip
    Permission granted by Alexion
    Image attribution tooltip
    Profile

    United by inequity: The healthcare disparities plaguing rare disease patients and Black Americans

    Guided by her personal experiences, Tamar Thompson is aiming to improve rare disease care through her advocacy work at Alexion, AstraZeneca Rare Disease.

    By Alexandra Pecci • Feb. 7, 2023
  • Yesmean Wahdan Bayer
    Image attribution tooltip
    Permission granted by Yesmean Wahdan Bayer
    Image attribution tooltip
    Podcast

    Woman of the Week: Bayer’s Dr. Yesmean Wahdan

    The VP of medical affairs and women’s health is focused on an audacious goal to meet the needs of 100 million women globally.

    By Feb. 1, 2023
  • Teens in circle holding smart mobile phones of different colors.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Patients are using social media — clinical trial experts can learn from that

    Why an alliance of industry leaders is exploring the potential of social media as a treasure trove of real-world patient experience insights. 

    By Karissa Waddick • Jan. 30, 2023
  • Ira Spector SFA Therapeutics
    Image attribution tooltip
    Permission granted by Ira Spector SFA Therapeutics
    Image attribution tooltip
    Profile

    A biotech CEO’s favorite ‘F’ word

    At SFA Therapeutics, patients are the “focus” of Ira Spector’s approach to changing the course of autoimmune disease.

    By Jan. 26, 2023
  • Johanna Mercier headshot
    Image attribution tooltip
    Permission granted by Gilead Sciences
    Image attribution tooltip
    Q&A

    Gilead’s commercial chief on why 2023 will be a ‘coming out’ year

    With a rapidly expanding oncology pipeline and a new approval in HIV, Johanna Mercier discusses Gilead’s quest to transform.

    By Jan. 26, 2023
  • Lauren Lazar Calcium
    Image attribution tooltip
    Permission granted by Lauren Lazar Calcium
    Image attribution tooltip
    Podcast

    Woman of the Week: Dr. Lauren Lazar

    As Calcium’s medical director, Lazar is leveraging next-generation innovation to create strategic connections between science and marketing for healthcare brands.

    By Jan. 25, 2023
  • Viewed from above, a rendering of the COVID-19 virus sits in the center of a clay, red basketball court.
    Image attribution tooltip
    Enes Evren via Getty Images
    Image attribution tooltip
    Profile

    Pro sports’ COVID protocols led to real-world data impacts for pharma

    After years of pioneering new methods for using data and technology to improve patient health outcomes, IQVIA’s Christina Mack is on the cusp of a research revolution.

    By Karissa Waddick • Jan. 16, 2023
  • financial storm
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    How biotechs can weather the market storm

    Execs at JPM sound off on moves companies can make to survive the challenging market conditions.

    By Jan. 13, 2023
  • pink hourglass
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Profile

    A new mission in menopause — extending the lives of women

    Why Evernow CEO Alicia Jackson thinks menopause is the perfect inroad to helping women live longer lives.

    By Jan. 5, 2023
  • spilled vial
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Nonprofits are bridging R&D’s valley of death

    How charitable firms such as Advancium are helping to right the market wrongs of drug development.

    By Kelly Bilodeau • Jan. 4, 2023
  • crystal ball 2023
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences

    A preview of the top trends on the minds of industry and market leaders for the new year.

    By Jan. 3, 2023
  • A person in a white lab coat holds an Ipad and pen and sits across from someone gesturing with their hands.
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip
    Q&A

    To drive trial diversity, one company is bringing them to the patient

    For Lightship, increasing patient access to clinical trials is about meeting them where they are — literally.

    By Karissa Waddick • Dec. 21, 2022
  • Signs in florida for a monkeypox vaccine site
    Image attribution tooltip
    Joe Raedle via Getty Images
    Image attribution tooltip

    With mpox cases mysteriously dwindling, scientists search for answers

    Was it a public health victory? Or did mpox ‘burn itself out?’ An epidemiologist weighs in.

    By Kelly Bilodeau • Dec. 19, 2022
  • Vicki Goodwin Exelexis
    Image attribution tooltip
    Permission granted by Exelexis’ Dr. Vicki Goodman
    Image attribution tooltip
    Podcast

    Woman of the Week: Exelixis’ Dr. Vicki Goodman

    With several blockbuster products under her belt, veteran oncologist and drug developer Dr. Vicki Goodman is looking to further evolve Exelixis’ pipeline to address hard-to-treat cancers.

    By Dec. 14, 2022